CD8A and cancer: These findings advanced our understanding of CD8 T cell heterogeneity in acute and chronic infections and cancer by clarifying the distinct roles of each subset (Chen et al., 2018; Hashimoto et al., 2018; Kaech and Cui, 2012; Martin and Badovinac, 2018; McLane et al., 2019).